Form 4: Anika Therapeutics EVP, CFO, and Treasurer Michael L. Levitz Reports Stock Transactions
SEC Form 4 Filing
Michael L. Levitz, EVP, CFO, and Treasurer of Anika Therapeutics, reports the vesting of restricted stock units and subsequent stock transactions to cover tax obligations.
Summary
- On March 11, 2024, Michael L. Levitz, EVP, CFO, and Treasurer of Anika Therapeutics, reported transactions involving common stock and restricted stock units (RSUs).
- These transactions included the vesting of RSUs granted on March 9, 2021, March 9, 2023, and March 11, 2022.
- A total of 4,438, 5,875, and 8,888 RSUs vested, respectively.
- The company retained 1,303, 1,725, and 2,610 shares of common stock to satisfy tax withholding obligations related to the vesting of these RSUs.
- Levitz also acquired 160 shares under the Employee Stock Purchase Plan on November 14, 2023.
- Following these transactions, Levitz directly owns 46,955 shares of Anika Therapeutics common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing reflects routine transactions related to stock-based compensation and tax obligations.
Positives
- The reporting person's continued holding of a significant number of shares (46,955) may indicate confidence in the company's future.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors to gauge sentiment and potential future actions.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in the number of outstanding shares, but the effect is likely minimal.
Key Dates
| Date | Description |
|---|---|
| 2021-03-09 | Date of grant for one set of Restricted Stock Units (RSUs) that vested in installments. |
| 2022-03-11 | Date of grant for one set of Restricted Stock Units (RSUs) that vested in installments. |
| 2023-03-09 | Date of grant for one set of Restricted Stock Units (RSUs) that vested in installments. |
| 2023-11-14 | Date of acquisition of shares under the Employee Stock Purchase Plan. |
| 2024-03-08 | Trading day prior to RSU vesting, ANIK closing price was $25.42. |
| 2024-03-11 | Date of transactions reported, including RSU vesting and tax withholding; ANIK closing price was $25.79. |
| 2024-03-12 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.